Non-small cell lung cancer

• The effect of oral folinic acid to prevent pemetrexed induced adverse events. Ended
  2022-502345-10-00 6 2023-02-05 "Non small cell lung cancer (NSCLC), Mesothelioma, Thymoma"
• A Phase 1b, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activ … Ended
  2022-500116-18-00 3 2023-01-09 "Advanced Solid Tumors"
• Phase 2 Study of MORAb-202 in Previously Treated Metastatic NSCLC AC Ended
  2023-504112-15-00 4 2023-01-04 "Metastatic Non-Small Cell Lung Cancer"
• An Open-label, Randomized, Three-period, Crossover Study to compare the Pharmacokinetics of GB1211 upon dosing a capsule under fasting condi … Ended
  2022-502200-67-00 3 2022-12-27 "Non-small Cell Lung Cancer"
• Phase I study of MGY825 in patients with lung cancer Ended
  2023-504350-36-00 1 2022-11-25 "Advanced non-small cell lung cancer with or without NFE2L2/K"
• A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors Ended
  2022-500094-14-00 1 2022-11-08 "gastroesophageal junction [GEJ] carcinoma"
• A PHASE 1/2 STUDY OF ONCOBAX®-AK ADMINISTERED IN COMBINATION WITH IMMUNOTHERAPY TO PATIENTS WITH ADVANCED SOLID TUMORS Ended
  2024-516711-24-00 7 2022-10-18 "Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RC"
• A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies Ended
  2023-504400-29-00 1 2022-09-15 "Advanced malignancies."
• A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08 , an IL-15 Antibody Fusion Protein Targeting CTLA-4, Mo … Ended
  2024-511750-53-00 7 2022-09-08 "Unresectable Locally Advanced or Metastatic Cancer"
• A Study of SGN-B7H4V in Advanced Solid Tumors Ended
  2023-503389-22-00 1 2022-08-31 "Fallopian tube cancer"
• A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS AND EFFICACY OF CYC140, AN ORAL PLK1 INHIBITOR, IN SU … Ended
  2024-516290-67-00 9 2022-08-03 "ADVANCED SOLID TUMORS AND LYMPHOMA"
• A Phase 1 open-label, first-in-human, multi-center, dose escalation and dose expansion study of CLN-619 administered alone or in combination … Ended
  2024-511744-27-00 1 2022-06-27 "Solid tumors, Non-Small Cell Lung Cancer, Cervical Cancer, E"
• Safety and preliminary efficacy trial of BNT142 in patients with CLDN6-positive advanced ovarian, lung, or testicular cancer Ended
  2024-512639-58-00 7 2022-05-07 "Solid Tumors"
• A Phase 1b, Open-Label, Dose-Escalation Trial of the Safety of and Antigen-Specific Immune Responses Elicited by VB.10 NEO in Combination Wi … Ended
  2023-509996-18-00 1 2022-01-18 "Locally advanced and metastatic solid tumor including non-sm"
• Phase 1b Study of Dato-DXd in Combination with Pembrolizumab with or without Platinum Chemotherapy in Advanced or Metastatic Non-Small Cell … Ended
  2023-508003-20-00 3 2021-09-27
• Study of Atezolizumab plus chemotherapy plus chemo-radiotherapy and Atezolizumab maintenance therapy in non-resectable non-small cell lung c … Ended
  2024-514803-33-00 4 2021-06-16 "Non-small cell lung cancer (NSCLC)"
• Phase 2 Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer with Actionable Genomic Alterations Ended
  2024-511449-21-00 4 2021-03-25 "Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)"
• Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants wit … Ended
  2023-508443-40-00 5 2020-12-18 "Lung Cancer, Non-Small Cell"
• TSRO-Ph2, Dostarlimab +CT vs Pembro +CT, 1L H2H efficacy comparison in Metastatic NSCLC pts. PERLA Ended
  2023-505894-33-00 4 2020-11-25 "Lung Cancer, Non-Small Cell"
• A Study of Tiragolumab, an Anti-TIGIT Antibody, in Combination with Atezolizumab Compared with Placebo in Combination with Atezolizumab (an … Ended
  2022-502482-17-00 5 2020-05-19 "Non-small cell lung cancer (NSCLC)"
• Safety, immunogenicity and preliminary clinical activity study of PDC*lung01 cancer vaccine in NSCLC Ended
  2024-517429-24-00 7 2020-01-09 "Non-small-cell lung cancer"
• REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer Ended
  2023-506248-18-00 7 2020-01-07 "MET-altered non-small cell lung cancer (NSCLC)"
• Neoadjuvant nivolumab combination treatment in resectable non-small cell lung cancer patients: Defining optimal combinations and determinant … Ended
  2024-513074-22-00 4 2019-12-02 "non-small cell lung cancer (NSCLC) of clinical stages IB, II"
• Precision Immuno-Oncology for advanced Non-small cell lung cancer patients with PD-1 ICI Resistance (PIONeeR clinical study) Ended
  2024-515532-72-00 4 2019-10-08 "non small cell lung cancer"

Showing 193–216 of 234 trials